Valuation: Medios AG

Market Cap 295M 337M 272M 252M 478M 32B 486M 3.26B 1.27B 15.79B 1.27B 1.24B 54.59B P/E 2026 *
10.9x
P/E 2027 * 8.62x
Enterprise Value 371M 424M 342M 317M 602M 40.26B 612M 4.1B 1.6B 19.87B 1.59B 1.56B 68.67B EV / Sales 2026 *
0.18x
EV / Sales 2027 * 0.16x
Free-Float
92.4%
Yield 2026 *
-
Yield 2027 * -
1 day+0.08%
1 week-0.66%
Current month-0.66%
1 month-3.23%
3 months-2.91%
6 months-21.26%
Current year-17.13%
1 week 11.8
Extreme 11.8
13
1 month 11.8
Extreme 11.8
13
Current year 11.64
Extreme 11.64
17.44
1 year 11.64
Extreme 11.64
17.44
3 years 9.98
Extreme 9.98
18.5
5 years 9.98
Extreme 9.98
41.6
10 years 7.41
Extreme 7.41
42
Manager TitleAgeSince
Chief Executive Officer 58 01/02/2026
Director of Finance/CFO 54 15/04/2026
Investor Relations Contact - -
Director TitleAgeSince
Chairman 53 07/11/2014
Director/Board Member 65 14/09/2016
Director/Board Member 57 10/06/2021
Date Insider Type Main position Quantity % Market Cap.
02-04Sell

Chief Executive Officer

13,638 0.0535%
01-22Buy

Executive/Senior Manager

4,000 0.0157%
19/08/24Buy

Executive/Senior Manager

10,000 0.0392%
Change 5-day change 1-year change 3-year change Capi.($)
+0.08%-0.66%-7.69%-27.54% 337M
-0.34%+3.13%+58.04%+171.20% 1,102B
-0.32%+5.16%+71.45%+67.45% 643B
-0.50%+0.91%+33.50%+88.37% 450B
+1.61%-2.07%+27.62%+22.57% 336B
-0.48%-0.21%+29.41%+48.77% 288B
-1.26%+2.30%-27.05%-40.07% 222B
-0.13%+1.46%+23.44%+63.14% 199B
-0.83%+7.51%+21.94%+78.93% 169B
+0.98%+1.38%-5.50%-32.15% 137B
Average -0.12%+1.77%+22.51%+44.07% 354.55B
Weighted average by Cap. -0.18%+1.86%+40.71%+86.31%

Financials

2026 *2027 *
Net sales 2.08B 2.38B 1.92B 1.78B 3.38B 226B 3.43B 23B 8.94B 111B 8.93B 8.74B 385B 2.14B 2.44B 1.97B 1.83B 3.47B 232B 3.52B 23.63B 9.19B 114B 9.17B 8.97B 396B
Net income 27.41M 31.32M 25.26M 23.41M 44.44M 2.97B 45.16M 303M 118M 1.47B 118M 115M 5.07B 34.51M 39.43M 31.8M 29.48M 55.96M 3.74B 56.86M 381M 148M 1.85B 148M 145M 6.38B
Net Debt 76.15M 87.02M 70.18M 65.05M 123M 8.26B 125M 842M 327M 4.08B 327M 320M 14.09B 40.72M 46.54M 37.53M 34.79M 66.04M 4.42B 67.1M 450M 175M 2.18B 175M 171M 7.53B
Logo Medios AG
Medios AG, formerly Crevalis Capital AG, is a Germany-based company offering solutions in pharma industry. The Company covers relevant aspects of supply chain like from pharmaceutical supply and manufacture of patient-specific therapies, including blistering and others. It operates in two segments Pharmaceutical supply which focuses on pharmaceutical wholesale with finished specialty pharma (high-priced drugs for rare and chronic diseases) medications including oncology, neurology, autoimmunology, ophthalmology, infectiology, hemophilia along with offering finished medicinal products; Patient-specific therapies focusing on pharmaceutical manufacturing of patient-specific preparations such as Cytostatic infusions, Antibody therapies, Virostatic and antibiotic medications, Parenteral nutrition solutions, Investigational medicinal products are among others. Its products and services include Patient health & protection and procedures & processes for patient care and digitalization of data.
Employees
993
Date Price Change Volume
08/07/26 12.00 -0.33% 17,415
07/07/26 €12.04 -3.22% 17,156
06/07/26 €12.44 +0.16% 29,760
03/07/26 €12.42 +1.47% 10,480
02/07/26 €12.24 +0.99% 12,984
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
12.04EUR
Average target price
23.00EUR
Spread / Average Target
+91.03%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILM1 Stock